Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections

Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price than the injectable versions. The once-a-day pill, approved by the FDA just before Christmas, is the first and only oral GLP-1 medication on